Pacira BioSciences SVP Finance Lauren Riker disposes of 6,000 common shares worth $217,920
Bitget2026/10/09 23:08Pacira BioSciences SVP, Finance Lauren Riker exercised stock options for 6,000 shares at $32.35 on Oct. 8, 2026. Riker sold 6,000 shares at $36.32 on the same day. Directly held common stock position stood at 62,284 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-065566), on October 09, 2026, and is solely responsible for the information contained therein.
- Pacira BioSciences SVP, Finance Lauren Riker exercised stock options for 6,000 shares at $32.35 on Oct. 8, 2026.
- Riker sold 6,000 shares at $36.32 on the same day.
- Directly held common stock position stood at 62,284 shares following the transactions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CNN Enters Generative AI Partnership with Google
US Stock Market Movement | Nvidia-backed AI pharmaceutical company Iambic Therapeutics (IAM.US) debuts on Nasdaq, surging over 11% after opening
As of press time, the stock is up more than 11%, trading at $17.77.